BACKGROUND, Wilms tumor is one of the few pediatric cancers with well-defin
ed familial and genetic components. The authors assessed the risk of early-
onset cancers in first- and second-degree relatives of patients enrolled by
the National Wilms Tumor Study Group.
METHODS. Using a stratified sampling scheme that targeted 530 families of p
atients who were believed a priori to have a genetic contribution to their
disease, the authors conducted interviews regarding cancer occurrence in 42
58 family members from 296 families of patients with Wilms tumor. Reports o
f malignant neoplasms that occurred before 55 years of age were confirmed b
y review of medical records wherever possible. A period of risk was defined
for each family member based on calendar time and his or her relationship
to the proband.
RESULTS. Ninety-nine cancers were observed, whereas 126.8 were expected by
applying standard cancer rates for age and calendar period to the 120,885 p
erson-years at risk. The standardized incidence ratio (SIR) was O-E = 0.78
with 95% confidence interval (CI) of (0.64, 0.95). In subgroup analyses, th
e highest relative risks were observed for parents of the index case (O/E =
21/13.0 = 1.6, 95% CI = 1.0, 2.5) and for leukemia (O/E = 9/4.9 = 1.9, 95%
CI= 0.85,3.5).
CONCLUSIONS. The results of this study may provide reassurance to families
of children who have had Wilms tumor. Potential sources of bias included th
e low (56%) rate of participation of targeted families. In general, the bia
ses might have led to the underreporting of some cancers, especially in mor
e distant relatives. The possibility of a slight excess of cancer in parent
s of Wilms tumor patients could not be excluded. (C) 2001 American Cancer S
ociety.